Open Access

How the new ESC clinical practice guidelines on valvular heart disease could change the treatment of patients with aortic stenosis

Event: ESC CONGRESS 2017
Topic: Aortic valve disease
Session type: Satellite Symposium
Sponsored by Edwards Lifesciences
Date: 27 August 2017
Time: 13:00 - 13:45


4 presentations in this session

What is the evidence supporting the new valvular heart disease (VHD) guidelines regarding severe aortic stenosis (AS) treatment?

Speaker: Professor S. Windecker (Bern, CH)

New VHD guidelines – The european association for cardio-thoracic surgery (EACTS) / surgeon perspective.

Speaker: Professor M. Czerny (Freiburg, DE)

New VHD guidelines – What are the implications for the cardiologist?

Speaker: Professor M. Paul (Muenster, DE)

New VHD guidelines - What are the implications for patients?

Speaker: Professor J. Mehilli (Landshut, DE)

4 speakers from this session

Professor Stephan Windecker

Bern University Hospital, Inselspital, Bern (Switzerland)
29 presentations

Professor Martin Czerny

University Heart Center Freiburg, Freiburg (Germany)
11 presentations
0 follower

Professor Matthias Paul

University Hospital Munster - UKM, Muenster (Germany)
1 presentation
0 follower

Professor Julinda Mehilli

Hospital Landshut-Achdorf, Landshut (Germany)
24 presentations
1 follower

This platform is supported by

logo Novo Nordisk